U.S. Markets closed

Longboard Pharmaceuticals, Inc. (LBPH)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.1500-0.1900 (-4.38%)
At close: 04:00PM EDT

Longboard Pharmaceuticals, Inc.

4275 Executive Square
Suite 950
La Jolla, CA 92037
United States
619 592 9775

Full Time Employees21

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin R. LindPres, CEO, Sec. & Director875.13kN/A1976
Ms. Brandi L. Roberts CPA, M.B.A.Chief Financial Officer568.57kN/A1974
Mr. Chadwick J. Orevillo MPHVP & Head of OperationsN/AN/AN/A
Megan E. KnightHead of Investor RelationsN/AN/AN/A
Mr. Steven W. Spector J.D.Head of Bus. Devel. & Gen. CounselN/AN/A1965
Dr. Anne M. DanksVP & Head of Preclinical Devel.N/AN/AN/A
Dr. Jodi ParsonsVP & Head of Regulatory AffairsN/AN/AN/A
Dr. Randall E. Kaye M.D.Chief Medical OfficerN/AN/A1962
Mr. Gus CardenasVP & Head of Quality AssuranceN/AN/AN/A
Dr. Marco Peters Ph.D.VP & Head of Translational ScienceN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.

Corporate Governance

Longboard Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.